alexa Mortality and major morbidity in premature infants less than 31 weeks gestational age in the decade after introduction of surfactant.
Diabetes & Endocrinology

Diabetes & Endocrinology

Journal of Steroids & Hormonal Science

Author(s): GenzelBoroviczny O, MacWilliams S, Von Poblotzki M, Zoppelli L

Abstract Share this page

Abstract OBJECTIVE: Population- but also center-based mortality and major morbidity rates of premature infants are essential for prenatal counseling and quality control. METHODS: Records of all infants <30 + 6 weeks (n=674) admitted (1991-2000) to a single neonatal intensive care unit were reviewed and compared to the state-wide mortality. RESULTS: Six hundred and ninety-one infants were born in or transferred to the hospital and 600 infants (89\%) survived. The mean (SD) birth weight was 1018 g (+/-314) and the mean gestational age 27+5 weeks (+/-2.0). Mortalityand morbidity did not change significantly over the 10-year period but correlated inversely with gestational age from 45\% at 23(0/7) weeks to 5\% at 30(6/7) weeks. Study center mortality rate for extremely low birth weight infants with birth weight <750 g was significantly lower than reported for the entire state (local 25\%; Bavaria 36\% p = 0.0003). Thirty-four per cent (251/600) of the survivors had one or more major complications: intracranial hemorrhage III-IV 8\% (88/600), periventricular leucomalacia 6\% (41/600), bronchopulmonary dysplasia with oxygen requirement at 36 weeks 20\% (128/600), necrotizing enterocolitis 6\% (43/600), and retinopathy of prematurity grade III-IV 9\% (55/600). Survival without major morbidity increased from 32\% at 23 weeks to 92\% at 30 weeks. CONCLUSIONS: Despite changes in obstetric and neonatal care during the 1990s, mortality and major morbidity rates did not change significantly after the introduction of surfactant in 1991. Comparison of local, regional, national, and international mortality and morbidity rates are becoming more important in allocating resources and in decision-making at the limits of viability.
This article was published in Acta Obstet Gynecol Scand and referenced in Journal of Steroids & Hormonal Science

Relevant Expert PPTs

Relevant Speaker PPTs

  • Yi-Cheng Hu
    Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifentreated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study
    PPT Version | PDF Version
  • Arvind Goyal
    The effect of pelvic muscle exercises on urinary incontinency and self-esteem of elderly females with stress urinary incontinency, 2013
    PPT Version | PDF Version
  • Randhawa Ramanpreet
    Receiver Operating Characteristic curve analysis of Anthropometric Physiological and Biochemical indices and a comparison between four International definitions JSS, mATP-III, IDF and ATP-III for screening Metabolic Syndrome among Pre- and Postmenopausal Rural females of Amritsar (Punjab)
    PPT Version | PDF Version
  • Asma Javed
    Screening and Management of the female athlete triad
    PPT Version | PDF Version
  • Ashraf El Metwally
    Predictors of pap screening rates among female university students in Maritime Canada
    PPT Version | PDF Version
  • Audrey Steenbeek
    Predictors of pap screening rates among female university students in Maritime Canada
    PPT Version | PDF Version
  • Benicio Gutiérrez-Doña
    Structural equation modeling of male/female handwashing behaviors during the a (H1N1) pandemic influenza in 2009-2010
    PPT Version | PDF Version
  • Amila Orucevic
    Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCC’s TNM staging system on overall survival of Caucasian females with breast cancer: An institution’s 10 year experience
    PPT Version | PDF Version
  • Dorcas Ikhuenbor
    Female gender participation in the blood donation process in resource poor settings: Case study of Sokoto in North Western Nigeria
    PPT Version | PDF Version
  • Martha M Sklavos
    Anti-Müllerian hormone deficiency in females with inherited bone marrow failure syndromes
    PDF Version

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version